Policy / Pricing FDA floats new clinical trial reforms; Takeda punts Denali brain drug BioPharma DiveIn its budget request, the agency proposed a way to speed up early drug testing and help smaller biotech firms.Policy / PricingRead full story pharminent April 6, 2026 (Last updated: April 6, 2026) BioPharma Dive In its budget request, the agency proposed a way to speed up early drug testing and help smaller biotech firms. Policy / PricingRead full story Post navigation Previous: Neurocrine to acquire Prader-Will drug in $2.9B Soleno buyoutNext: Amgen scores with new thyroid eye disease formulation Related Stories Policy / Pricing MFN affecting Swiss medicines access, says Interpharma pharminent August 13, 2026 Policy / Pricing Prior Authorization Metrics Provide New Insights into Insurer Practices, but Gaps Remain pharminent August 13, 2026 Policy / Pricing Trump signs order that nearly halves childhood immunisation coverage pharminent August 11, 2026
